Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T13:50:53.809Z Has data issue: false hasContentIssue false

Optimized Protocol for the Use of Thermo-sensitive Liposome in Tumor Therapeutics

Published online by Cambridge University Press:  07 January 2014

Jae Min Cha
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea Samsung Biomedical Research Institute, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Seoul 135-710, Republic of Korea
Eun-Jung Choi
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea
Sang-Jun Park
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea
Sang-Ok Song
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea
Sun Min Park
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea
Kyu-Sil Choi
Affiliation:
Laboratory Animal Research Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea
Eun-Sung Park
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea
Hyun Ryoung Kim
Affiliation:
Bio Research Center, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Yongin-si, Gyeonggi-do 446-712, Republic of Korea
Get access

Abstract

Liposomal drug delivery products have been already commercialized in tumor therapeutics, which can realize passive tumor targeting via enhanced permeability and retention (EPR) effect resulting from the leaky tumor vasculature. To control drug release out of the liposomes, thermo-sensitive liposomes (TSLs) have been developed so that an abrupt exposure of highly concentrated drugs to tumor tissues was enabled by locally treated thermal stimuli. As interests upon TSL have increased along with ongoing clinical trials, some types of TSLs with different physical properties in pharmacokinetics and the mechanism of drug release have been formulated. However, there are few protocols established with a desirable heat source to maximize the efficacy of different TSLs as treating tumors. In this study, we examined different protocols for the most effective application of different TSLs to tumor therapy. First, we examined if enhancing the accumulation of TSLs within tumor tissues prior to bursting drugs out of TSLs could lead to increasing anti-tumor efficacy. Second, we compared the efficiency of two different heat sources on the use of TSL, a warm water bath (42°C) and high intensity focused ultrasound (HIFU). Our study suggests that the specified protocol be setup for TSLs with different physical properties to optimally function in tumor therapies.

Type
Articles
Copyright
Copyright © Materials Research Society 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J. Y., Simnick, A. J., Dreher, M. R., Das, S., Hanna, G., Park, W., Chilkoti, A., Koning, G. A., ten Hagen, T. L., Needham, D. and Dewhirst, M. W., Cancer Res. 72, 21 (2012).CrossRefGoogle Scholar
Allen, T. M. and Cullis, P. R., Adv. Drug Deliv. Rev. 65, 1 (2013).CrossRefGoogle Scholar
He, C., Hu, Y., Yin, L., Tang, C. and Yin, C., Biomaterials. 31, 13 (2010).Google Scholar
Immordino, M. L., Dosio, F. and Cattel, L., Int. J. Nanomedicine. 1, 3 (2006).Google Scholar
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D. and Dewhirst, M. W., Cancer Res. 60, 24 (2000).Google Scholar
Li, L., ten Hagen, T. L., Schipper, D., Wijnberg, T. M., van Rhoon, G. C., Eggermont, A. M., Lindner, L. H. and Koning, G. A., J. Control Release. 143, 2 (2010).CrossRefGoogle Scholar
Li, L., ten Hagen, T. L., Hossann, M., Suss, R., van Rhoon, G. C., Eggermont, A. M., Haemmerich, D. and Koning, G. A., J. Control Release. 168, 2 (2013).Google Scholar
Park, S. M. et al. . J.Controlled Release. 170, 3 (2013).Google Scholar
Stylianopoulos, T., Ther. Deliv. 4, 4 (2013).CrossRefGoogle Scholar
Needham, D., Anyarambhatla, G., Kong, G. and Dewhirst, M. W., Cancer Res. 60, 5 (2000).Google Scholar